Patients with Asthma, COPD or allergies which target the airway are especially affected by the Covid-19 pandemic. What infection risk in general, and which targeted therapies are important for these specific risk groups?
Prof. Roland Buhl (Global Initiative for Asthma – GINA)
Prof. Mathias Pletz, Prof. Oliver Pfaar, and Prof. Claus Vogelmeier (Global Initiative for Chronic Obstructive Lung Disease – GOLD)
Aufgezeichnet am 9.4.2020